Rep. Lisa C. McClain Buys GSK PLC Sponsored ADR (NYSE:GSK) Shares

Key Points

• Representative Lisa C. McClain purchased shares of GSK PLC for between $1,001 and $15,000 on June 17th, according to a filing dated August 13th.
• GSK reported an earnings per share (EPS) of $1.23 for the last quarter, surpassing analysts' expectations and indicating a revenue growth of 1.3% year-over-year.
• The pharmaceutical company has announced a quarterly dividend of $0.4206 per share, reflecting an annualized yield of 4.2% and a payout ratio of 77.78%.

Representative Lisa C. McClain (R-Michigan) recently bought shares of GSK PLC Sponsored ADR NYSE: GSK. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in GSK stock on June 17th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
• Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

GSK Stock Performance

GSK stock traded up $0.18 during midday trading on Tuesday, reaching $39.82. 2,280,585 shares of the company traded hands, compared to its average volume of 3,755,246. The firm has a market capitalization of $81.10 billion, a price-to-earnings ratio of 18.43, a price-to-earnings-growth ratio of 1.72 and a beta of 0.51. The business has a 50 day moving average of $38.33 and a two-hundred day moving average of $38.16. GSK PLC Sponsored ADR has a 12 month low of $31.72 and a 12 month high of $44.67. The company has a debt-to-equity ratio of 1.07, a current ratio of 0.87 and a quick ratio of 0.57.

GSK (NYSE:GSK - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The pharmaceutical company reported $1.23 earnings per share for the quarter, beating analysts' consensus estimates of $1.12 by $0.11. The company had revenue of $10.64 billion for the quarter, compared to the consensus estimate of $7.92 billion. GSK had a net margin of 10.81% and a return on equity of 49.22%. The firm's revenue for the quarter was up 1.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.43 earnings per share. GSK has set its FY 2025 guidance at 4.590-4.590 EPS. As a group, research analysts predict that GSK PLC Sponsored ADR will post 4.14 earnings per share for the current year.

GSK Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 9th. Investors of record on Friday, August 15th will be given a dividend of $0.4206 per share. The ex-dividend date is Friday, August 15th. This represents a $1.68 dividend on an annualized basis and a yield of 4.2%. GSK's dividend payout ratio is 77.78%.

Institutional Investors Weigh In On GSK

Institutional investors have recently bought and sold shares of the business. Brighton Jones LLC purchased a new stake in GSK in the 4th quarter worth $528,000. First Hawaiian Bank increased its stake in GSK by 18.8% in the 1st quarter. First Hawaiian Bank now owns 101,039 shares of the pharmaceutical company's stock worth $3,914,000 after buying an additional 15,987 shares in the last quarter. Forum Financial Management LP increased its stake in GSK by 167.9% in the 4th quarter. Forum Financial Management LP now owns 13,397 shares of the pharmaceutical company's stock worth $453,000 after buying an additional 8,396 shares in the last quarter. Barclays PLC increased its stake in GSK by 84.2% in the 4th quarter. Barclays PLC now owns 49,628 shares of the pharmaceutical company's stock worth $1,678,000 after buying an additional 22,689 shares in the last quarter. Finally, Crestline Management LP purchased a new stake in GSK in the 4th quarter worth $1,047,000. Hedge funds and other institutional investors own 15.74% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have commented on GSK shares. Berenberg Bank reaffirmed a "hold" rating on shares of GSK in a report on Tuesday, June 3rd. Hsbc Global Res raised shares of GSK to a "strong sell" rating in a report on Monday, April 28th. Finally, Wall Street Zen raised shares of GSK from a "hold" rating to a "buy" rating in a report on Sunday, August 3rd. Seven analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Reduce" and an average target price of $37.38.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.